Business models in biotech

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2000 English Publisher:Springer Science and Business Media LLCJournal:Nature Biotechnology, volume 18, pages IT3-IT4 (issn: 1087-0156, eissn: 1546-1696,

Copyright policy )

Authors: S, Papadopoulos;

doi: 10.1038/80065

pmid: 11055590

Business models in biotech

- Summary
- Subjects
- Metrics

Abstract

Companies with technology platforms that address only a tiny part of the drug discovery process risk becoming optional or redundant accessories.

Keywords

Models, Economic, Commerce, Biotechnology

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	6
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average